Homologous recombination (HR) deficiency, tumor BRCA1/2 mutations (tmBRCA) and association with response and outcome following platinum monotherapy in high grade serous ovarian cancer (HGSOC).

File(s)

Homologous recombination-Abstract.docx (15.63 KB)

Published version

Show more

Author(s)

Brown, R

Timms, K

Paul, J

Hughes, E

El-Bahrawy, M

more

Type

Conference Paper

Date Issued

2015-05-20

Date Acceptance

2015-05-01

Citation

Journal of Clinical Oncology, 2015, 33 (15)

URI

http://hdl.handle.net/10044/1/53272

DOI

https://www.dx.doi.org/10.1200/jco.2015.33.15_suppl.5576

ISSN

0732-183X

Publisher

American Society of Clinical Oncology

Journal / Book Title

Journal of Clinical Oncology

Volume

33

Issue

15

Copyright Statement

© 2015 American Society of Clinical Oncology

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036901241&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Source

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

Publication Status

Published

Start Date

2015-05-29

Finish Date

2015-06-02

Coverage Spatial

Chicago, IL